Literature DB >> 1383201

Cloning and characterization of human cyclin D3, a cDNA closely related in sequence to the PRAD1/cyclin D1 proto-oncogene.

T Motokura1, K Keyomarsi, H M Kronenberg, A Arnold.   

Abstract

Cyclins regulate cell cycle progression by complexing with and activating cdc2 or related kinases. PRAD1/cyclin D1 is a recently discovered putative oncogene in several types of human tumors and may regulate G1-S phase progression. We have cloned a related human cDNA, called cyclin D3, from a placental cDNA library by cross-hybridization with PRAD1. In synchronized HeLa cells, the mRNA levels of PRAD1 and cyclin D3 were regulated reciprocally through the cell cycle: cyclin D3 mRNA levels peaked in S phase, where PRAD1 mRNA was lowest in S. In normal human mammary epithelial (70N) cells synchronized by growth factor deprivation and subsequent growth factor stimulation, PRAD1 expression peaked in G1 and declined before S phase, while cyclin D3 expression rose later in G1 and remained elevated in S. Therefore, the close relationship (53.1% identity) between PRAD1 and cyclin D3 does not necessarily imply redundant functions of these candidate G1 cyclins; they may have distinct roles in progression from G1 through S phase.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1383201

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Herpes simplex virus 1 alpha regulatory protein ICP0 interacts with and stabilizes the cell cycle regulator cyclin D3.

Authors:  Y Kawaguchi; C Van Sant; B Roizman
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells.

Authors:  M Meyyappan; H Wong; C Hull; K T Riabowol
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

3.  A critical role for cyclin C in promotion of the hematopoietic cell cycle by cooperation with c-Myc.

Authors:  Z J Liu; T Ueda; T Miyazaki; N Tanaka; S Mine; Y Tanaka; T Taniguchi; H Yamamura; Y Minami
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

4.  Early increase in cyclin-D1 expression and accelerated entry of mouse hepatocytes into S phase after administration of the mitogen 1, 4-Bis[2-(3,5-Dichloropyridyloxy)] benzene.

Authors:  G M Ledda-Columbano; M Pibiri; R Loi; A Perra; H Shinozuka; A Columbano
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

5.  Genetic replacement of cyclin D1 function in mouse development by cyclin D2.

Authors:  Bradley C Carthon; Carola A Neumann; Manjusri Das; Basil Pawlyk; Tiansen Li; Yan Geng; Piotr Sicinski
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

6.  Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression.

Authors:  E A Musgrove; J A Hamilton; C S Lee; K J Sweeney; C K Watts; R L Sutherland
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

7.  cDNA cloning, sequence identification and tissue expression distribution of three novel porcine genes: UCHL3, RIT1 and CCND3.

Authors:  G Y Liu
Journal:  Mol Biol Rep       Date:  2008-01-17       Impact factor: 2.316

8.  p53, Ki67 and cyclin D1 as prognosticators of lymph node metastases in laryngeal carcinoma.

Authors:  D Mielcarek-Kuchta; J Olofsson; W Golusinski
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-10-09       Impact factor: 2.503

9.  Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases.

Authors:  Y Geng; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

10.  Distinct cyclin D genes show mitotic accumulation or constant levels of transcripts in tobacco bright yellow-2 cells.

Authors:  D A Sorrell; B Combettes; N Chaubet-Gigot; C Gigot; J A Murray
Journal:  Plant Physiol       Date:  1999-01       Impact factor: 8.340

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.